Credit Available: ACPE, CME, NCPD
Enroll in this Course
This webinar will focus on the latest developments in myeloma, current and emerging treatments, including clinical trials, and evidence-based treatment strategies for optimal patient care. Information on education and support resources for patients, caregivers, and healthcare professionals will also be provided.
Time to Complete Activity: 1.25 hours
This course is available from:
February 13, 2024 until February 12, 2025
This activity is intended for hematologists-oncologists, medical oncologists, nurse practitioners, nurses and pharmacists involved in the care of patients with myeloma.
After completing this activity, the participant should be better able to:
- Describe the latest developments in myeloma, including current and emerging treatments
- Engage patients and caregivers in discussions on clinical trials, newly approved therapies and emerging therapies for myeloma, including combination therapies, CAR T-cell therapy and bispecific antibodies
- Identify strategies for optimal patient care
- Apply evidence-based treatment strategies
- Access patient support resources
Accreditation, Support and Credit
In support of improving patient care, this activity has been planned and implemented by Medical Learning Institute, Inc., and The Leukemia & Lymphoma Society. Medical Learning Institute, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education
Medical Learning Institute, Inc. (MLI) designates this enduring material activity for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Continuing Pharmacy Education
Medical Learning Institute, Inc. designates this continuing education activity for 1.25 contact hours (0.125 CEUs) of the Accreditation Council for Pharmacy Education.
Universal Activity Number: JA0007322-9999-24-016-H01-P
Type of Activity: Application
Nursing Continuing Professional Development
Approval for nurses has been obtained by the National Office of The Leukemia & Lymphoma Society under Provider Number CEP 5832 to award 1.25 continuing education contact hours through the California Board of Registered Nursing.
Nurse Practitioner Continuing Education
“This education activity is pending approval by the American Association of Nurse Practitioners® of up to 1.25 contact hours of accredited education.”
Interprofessional Continuing Education (IPCE) Statement
This activity was planned by and for the healthcare team, and learners will receive 1.25 Interprofessional Continuing Education (IPCE) credits for learning and change.
This activity is supported in part by an independent educational grant from Bristol Myers Squibb. Additional funding provided by The Leukemia & Lymphoma Society.
This activity is provided by The Leukemia & Lymphoma Society and Medical Learning Institute, Inc.
Disclosure of Conflicts of Interest Policy
Medical Learning Institute, Inc. and The Leukemia & Lymphoma Society, are committed to providing high quality continuing education to healthcare professionals, as individuals and teams, with a protected space to learn, teach, and engage in scientific discourse free from influence from ineligible companies that may have an incentive to insert commercial bias into education. To that end, MLI requires faculty, presenters, planners, staff, and other individuals who are in a position to control the content of this CE activity to disclose all financial relationships they have had in the past 24 months with ineligible companies as defined by the ACCME, as related to the content of this CE activity, regardless of the amount or their view of the relevance to the education. All identified COI will be thoroughly vetted and mitigated according to MLI policy. These disclosures will be provided to learners prior to the start of the CE activity.
Edward A. Stadtmauer, MD*, has a financial interest/relationship or affiliation in the form of:
Advisory Board/Consultant: AbbVie, Amgen, Bristol Myers Squibb, Janssen
Research Grant: AbbVie
Cindy Varga, MD*, has a financial interest/relationship or affiliation in the form of:
The following relationships have ended within the last 24 months:
Advisory Board/Consultant: Arcellx
Planning Committee and Content/Peer Reviewers
The planners and content/peer reviewers from Medical Learning Institute, Inc. and The Leukemia & Lymphoma Society do not have any relevant financial relationships to disclose with ineligible companies unless listed below.
Lauren Berger, MPH
The Leukemia & Lymphoma Society
Lauren Berger, MPH, has a financial interest/relationship or affiliation in the form of:
Stock Ownership with Bristol Myers Squibb, Gilead Sciences, Inc., Merck & Co., Inc., Organon & Co., Pfizer Inc., and Viatris Inc.
All of the relevant financial relationships of individuals for this activity have been mitigated.
Disclosure of Unlabeled Use
This educational activity may contain discussions of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this CE activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the accredited CE activity are those of the presenters and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this CE activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this CE activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Method of Participation
There are no fees for participating in or receiving credit for this CE activity. In order to receive credit, learners must participate in the entire CE activity, complete the activity posttest, evaluation form and your certificate of credit will be generated. A passing score of 70% or higher is needed to obtain credit. You will receive your certificate from Medical Learning Institute, Inc.
For Pharmacists, Medical Learning Institute will accept your completed evaluation form for up to 30 days post-activity and will report your participation to the NABP only if you provide your NABP e-Profile number and DOB (MM/DD). Within 6 weeks, you can view your participation record at the NABP website: https://nabp.pharmacy/
For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.
If you have questions regarding your certificate, please contact Mary Vu via email at email@example.com
For questions, concerns, or for assistance for people with disabilities or grievances, please contact us at ProfEducation@LLS.org.
About this Activity
Medical Learning Institute, Inc. and The Leukemia & Lymphoma Society are responsible for the selection of this activity’s topics, the preparation of editorial content, and the distribution of this CE activity. Our activities may contain references to unapproved products or uses of these products in certain jurisdictions.
The materials presented here are used with the permission of the authors and/or other sources. These materials do not necessarily reflect the views of Medical Learning Institute, Inc. or any of its partners, providers, and/or supporters.
Copyright © 2024 Medical Learning Institute, Inc. All Rights Reserved.
- Resources for You
- Resources for Patients
- FREE CME and CE courses for healthcare professionals: www.LLS.org/CE
- Treating Blood Cancers: Podcast series for healthcare professionals: www.LLS.org/HCPpodcast. Experts discuss the latest developments in blood cancers, new and emerging treatment options, side-effect management, survivorship issues, and more.
- LLS Online Community: HCP, Patient/Survivor & Caregiver account types: www.LLS.org/community
- Safe and secure site dedicated to research and has been created to support those living with blood cancer, their closest family members and healthcare professionals.
- Clinical Trial Nurse Navigators: Patients & caregivers work one-on-one with an LLS Clinical Trial Nurse Navigator who will help find clinical trials and personally assist throughout the clinical trial process, providing an additional resource to the HCP team – www.LLS.org/navigation
- Information Resource Center: Information Specialist are nurses, social workers, and health educators who assist through treatment, financial, and social challenges. They offer up-to-date disease and treatment information – www.LLS.org/IRC
- Myeloma: www.LLS.org/myeloma
- Telephone and web education programs: www.LLS.org/Programs
- Education Videos: www.LLS.org/Educationvideos
- Podcasts: www.LLS.org/LLS-podcast
- Free booklets and fact sheets on disease, treatment and survivorship: www.LLS.org/Booklets
- Support resources: www.LLS.org/Support
- Financial assistance
- Travel Assistance
- Referral to medication access programs
- Patient Aid
- Urgent Need
- Veteran Dental Financial Assistance (See website for location and application details)
- LLS regions
- LLS Community (social media platform)
- Weekly online chats (facilitated by oncology social workers)
- Patti Robinson Kaufman First Connection Program (peer-to-peer)
- Nutrition Education Services Center (1:1 nutrition consultation with registered dietitians)
- Clinical Trial Support Center Nurse Navigators: Patients & caregivers work one-on-one with an LLS Clinical Trial Nurse Navigator who will help find clinical trials and personally assist throughout the clinical trial process, providing an additional resource to the HCP team – www.LLS.org/navigation
- Information Resource Center: Information Specialist are nurses, social workers, and health educators who assist through treatment, financial, and social challenges. They offer up-to-date disease and treatment information– www.LLS.org/IRC
- Phone: (800) 955-4572, M-F, 9 am to 9 pm
- Contact Us: https://www.lls.org/form/contact-us
- Live chat: www.LLS.org/InformationSpecialists
- Financial assistance